Related Experiment Videos
Social Normalization of Young Cancer Survivors: A Scoping Review Using Meleis' Transitions Theory
1University of Maryland School of Nursing, Baltimore, Maryland, USA.
Journal of Advanced Nursing
|July 27, 2026
Summary
Social normalization for young cancer survivors (ages 10-24) is a dynamic process influenced by developmental and illness transitions. Supportive environments and coordinated care are crucial for their reintegration and well-being.
Area of Science:
- Oncology
- Developmental Psychology
- Sociology
Background:
- Young cancer survivors (ages 10-24) face unique challenges in social reintegration.
- Existing research often prioritizes physical late effects over social outcomes.
- Understanding social normalization is critical for long-term survivorship care.
Purpose of the Study:
- To synthesize evidence on social normalization in young cancer survivors (ages 10-24).
- To identify transition conditions and response patterns influencing their experiences.
- To inform developmentally attuned and socially responsive survivorship care.
Main Methods:
- A scoping review was conducted using Arksey and O'Malley's framework.
- Data were extracted and synthesized from 32 studies by two independent reviewers.
- Meleis' Transitions Theory guided the synthesis of findings.
Main Results:
- Identified personal factors (identity, psychological state, functioning) and environmental factors (peer, family, professional support).
- Social normalization is shaped by simultaneous developmental and illness transitions ('double transitions').
- Cascading effects of disruptions (e.g., isolation) impact multiple functioning levels; protective mechanisms include autonomy support and coordinated communication.
Conclusions:
- Social normalization is an ongoing developmental process for young cancer survivors, involving identity integration, relational negotiation, and role participation.
- Autonomy-supportive environments and coordinated care across healthcare, school, and community settings are essential.
- Findings provide process-oriented guidance for supporting reintegration and long-term well-being.
Related Concept Videos
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...